An Elevated Fetal Interleukin-6 Concentration Can Be Observed in Fetuses with Anemia Due to Rh Alloimmunization: Implications for the Understanding of the Fetal Inflammatory Response Syndrome
Overview
Authors
Affiliations
Objective: The fetal inflammatory response syndrome (FIRS) has been described in the context of preterm labor and preterm prelabor rupture of the membranes and is often associated with intra-amniotic infection/inflammation. This syndrome is characterized by systemic fetal inflammation and operationally defined by an elevated fetal plasma interleukin (IL)-6. The objective of this study was to determine if FIRS can be found in fetuses with activation of their immune system, such as the one observed in Rh alloimmune-mediated fetal anemia.
Methods: Fetal blood sampling was performed in sensitized Rh-D negative women with suspected fetal anemia (n=16). Fetal anemia was diagnosed according to reference range nomograms established for the assessment of fetal hematologic parameters. An elevated fetal plasma IL-6 concentration was defined using a cutoff of >11 pg/ml. Concentrations of IL-6 were determined by immunoassay. Non-parametric statistics were used for analysis.
Results: (1) The prevalence of an elevated fetal plasma IL-6 was 25% (4/16); (2) there was an inverse relationship between the fetal hematocrit and IL-6 concentration -- the lower the hematocrit, the higher the fetal IL-6 (r=-0.68, p=0.004); (3) fetuses with anemia had a significantly higher plasma IL-6 concentration than those without anemia (3.74 pg/ml, interquartile range (IQR) 1.18-2.63 vs. 1.46 pg/ml, IQR 1.76-14.7; p=0.02); (4) interestingly, all fetuses with an elevated plasma IL-6 concentration had anemia (prevalence 40%, 4/10), while in the group without anemia, none had an elevated fetal plasma IL-6.
Conclusions: An elevation in fetal plasma IL-6 can be observed in a subset of fetuses with anemia due to Rh alloimmunization. This observation suggests that the hallmark of FIRS can be caused by non-infection-related insults. Further studies are required to determine whether the prognosis of FIRS caused by intra-amniotic infection/inflammation is different from that induced by alloimmunization.
Giovannini E, Bonasoni M, Pascali J, Giorgetti A, Pelletti G, Gargano G Microorganisms. 2023; 11(4).
PMID: 37110434 PMC: 10142209. DOI: 10.3390/microorganisms11041010.
Nomiyama M, Nakagawa T, Yamasaki F, Hisamoto N, Yamashita N, Harai A Biomedicines. 2023; 11(2).
PMID: 36831147 PMC: 9953376. DOI: 10.3390/biomedicines11020611.
Jawor P, Mee J, Stefaniak T Animals (Basel). 2021; 11(7).
PMID: 34359230 PMC: 8300098. DOI: 10.3390/ani11072102.
Sepsis, Cytokine Storms, and Immunopathology: The Divide between Neonates and Adults.
Greenfield K, Badovinac V, Griffith T, Knoop K Immunohorizons. 2021; 5(6):512-522.
PMID: 34183380 PMC: 8686527. DOI: 10.4049/immunohorizons.2000104.
Kabyemela E, Fried M, Kurtis J, Moses G, Gorres J, Muehlenbachs A Front Immunol. 2021; 12:624136.
PMID: 33995348 PMC: 8120033. DOI: 10.3389/fimmu.2021.624136.